Local Institution - 011-202

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Schizophrenia

Closed trials

• Completed

  An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)

  NCT04820309· Phase 3· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Source